Dany Raad1, Swarna Gaddam2, Holger J Schunemann3, Jihad Irani4, Philippe Abou Jaoude1, Roland Honeine1, Elie A Akl5. 1. Department of Medicine, State University of New York at Buffalo, Buffalo, NY. 2. Department of Family Medicine, State University of New York at Buffalo, Buffalo, NY. 3. Department of Medicine, State University of New York at Buffalo, Buffalo, NY; Department of Family Medicine, State University of New York at Buffalo, Buffalo, NY. 4. Faculty of Health Sciences, University of Balamand, Beirut, Lebanon. 5. Department of Medicine, State University of New York at Buffalo, Buffalo, NY; Department of Family Medicine, State University of New York at Buffalo, Buffalo, NY; Departments of Clinical Epidemiology and Biostatistics and Medicine, McMaster University, Hamilton, ON, Canada. Electronic address: elieakl@buffalo.edu.
Abstract
BACKGROUND: Although common in many Middle Eastern countries, water-pipe tobacco smoking, commonly known as water-pipe smoking (WPS), is increasingly popular in Western cultures. The primary objective of this study was to systematically review the effects of WPS on lung function. The secondary objective was to compare the effects of WPS and cigarette smoking on lung function. METHODS: We conducted a systematic review using the approach of the Cochrane Collaboration to search for, select, and abstract studies. We conducted two separate meta-analyses comparing water-pipe smokers with nonsmokers, and water-pipe smokers with cigarette smokers for each of three spirometric measurements (FEV₁, FVC, and FEV₁/ FVC). We used the standardized mean difference (SMD) to pool the results. RESULTS: Six cross-sectional studies were eligible for this review. Compared with no smoking, WPS was associated with a statistically significant reduction in FEV₁ (SMD = -0.43; 95% CI, -0.58 to -0.29; equivalent to a 4.04% lower FEV₁%), a trend toward lower FVC (SMD = -0.15; 95% CI, -0.34 to 0.04; equivalent to a 1.38% reduction in FVC%), and lower FEV₁/ FVC (SMD = -0.46; 95% CI, -0.93 to 0.01; equivalent to a 3.08% lower FEV₁/ FVC). Comparing WPS with cigarette smoking, there was no statistically significant difference in FEV₁, FVC, and FEV₁/ FVC. The six studies suffered from methodologic limitations. CONCLUSIONS: WPS negatively affects lung function and may be as harmful as cigarette smoking. WPS, therefore, is likely to be a cause of COPD.
BACKGROUND: Although common in many Middle Eastern countries, water-pipe tobacco smoking, commonly known as water-pipe smoking (WPS), is increasingly popular in Western cultures. The primary objective of this study was to systematically review the effects of WPS on lung function. The secondary objective was to compare the effects of WPS and cigarette smoking on lung function. METHODS: We conducted a systematic review using the approach of the Cochrane Collaboration to search for, select, and abstract studies. We conducted two separate meta-analyses comparing water-pipe smokers with nonsmokers, and water-pipe smokers with cigarette smokers for each of three spirometric measurements (FEV₁, FVC, and FEV₁/ FVC). We used the standardized mean difference (SMD) to pool the results. RESULTS: Six cross-sectional studies were eligible for this review. Compared with no smoking, WPS was associated with a statistically significant reduction in FEV₁ (SMD = -0.43; 95% CI, -0.58 to -0.29; equivalent to a 4.04% lower FEV₁%), a trend toward lower FVC (SMD = -0.15; 95% CI, -0.34 to 0.04; equivalent to a 1.38% reduction in FVC%), and lower FEV₁/ FVC (SMD = -0.46; 95% CI, -0.93 to 0.01; equivalent to a 3.08% lower FEV₁/ FVC). Comparing WPS with cigarette smoking, there was no statistically significant difference in FEV₁, FVC, and FEV₁/ FVC. The six studies suffered from methodologic limitations. CONCLUSIONS: WPS negatively affects lung function and may be as harmful as cigarette smoking. WPS, therefore, is likely to be a cause of COPD.
Authors: Brian A Primack; Ariel Shensa; Kevin H Kim; Mary V Carroll; Mary T Hoban; E Victor Leino; Thomas Eissenberg; Kathleen H Dachille; Michael J Fine Journal: Nicotine Tob Res Date: 2012-05-28 Impact factor: 4.244
Authors: Susanne B Montgomery; Maria De Borba-Silva; Pramil Singh; Hildemar Dos Santos; Jayakaran S Job; T L Brink Journal: Calif J Health Promot Date: 2015
Authors: Brian A Primack; Peter Freedman-Doan; Jaime E Sidani; Daniel Rosen; Ariel Shensa; A Everette James; John Wallace Journal: Am J Prev Med Date: 2015-09-15 Impact factor: 5.043
Authors: Omar F Khabour; Karem H Alzoubi; Mohammed Bani-Ahmad; Arwa Dodin; Thomas Eissenberg; Alan Shihadeh Journal: Inhal Toxicol Date: 2012-08 Impact factor: 2.724